One of the best ways to learn about the capabilities of RCTdesign is to see how it can be used in the context of real clinical trials.  Periodically we will update RCTdesign.org with case studies as we develop them.

A randomized clinical trial of an experimental monoclonal antibody in chronic lymphocytic leukemia (CLL).

1. Summary: This document describes the design, monitoring, and analysis of a randomized, double blind, placebo controlled randomized clinical trial using a time to event endpoint. All RCTdesign code used to produce tables and plots is included in the appendix.
   

2. Ref: Gillen DL,Emerson SS, Proceedings of the Fourth Seattle Symposium (to appear).
   

1. 
   

2.    
   

1.